Black Rock Inc. Cytokinetics Inc Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Black Rock Inc. holds 12,414,773 shares of CYTK stock, worth $602 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
12,414,773
Previous 16,102,070
22.9%
Holding current value
$602 Million
Previous $1.34 Billion
35.26%
% of portfolio
0.02%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding CYTK
# of Institutions
459Shares Held
108MCall Options Held
7.2MPut Options Held
6.2M-
Vanguard Group Inc Valley Forge, PA10MShares$485 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.12MShares$248 Million0.22% of portfolio
-
Bank Of America Corp Charlotte, NC4.78MShares$232 Million0.03% of portfolio
-
State Street Corp Boston, MA4.52MShares$219 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.98MShares$193 Million0.05% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.57B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...